Cost of disorders of the brain in Europe 2010
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Cost of disorders of the brain in Europe 2010. / Gustavsson, Anders; Svensson, Mikael; Jacobi, Frank; Allgulander, Christer; Alonso, Jordi; Beghi, Ettore; Dodel, Richard; Ekman, Mattias; Faravelli, Carlo; Fratiglioni, Laura; Gannon, Brenda; Jones, David Hilton; Jennum, Poul; Jordanova, Albena; Jönsson, Linus; Karampampa, Korinna; Knapp, Martin; Kobelt, Gisela; Kurth, Tobias; Lieb, Roselind; Linde, Mattias; Ljungcrantz, Christina; Maercker, Andreas; Melin, Beatrice; Moscarelli, Massimo; Musayev, Amir; Norwood, Fiona; Preisig, Martin; Pugliatti, Maura; Rehm, Juergen; Salvador-Carulla, Luis; Schlehofer, Brigitte; Simon, Roland; Steinhausen, Hans-Christoph; Stovner, Lars Jacob; Vallat, Jean-Michel; den Bergh, Peter Van; van Os, Jim; Vos, Pieter; Xu, Weili; Wittchen, Hans-Ulrich; Jönsson, Bengt; Olesen, Jes; CDBE2010Study Group.
In: European Neuropsychopharmacology, Vol. 21, No. 10, 2011, p. 718-79.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cost of disorders of the brain in Europe 2010
AU - Gustavsson, Anders
AU - Svensson, Mikael
AU - Jacobi, Frank
AU - Allgulander, Christer
AU - Alonso, Jordi
AU - Beghi, Ettore
AU - Dodel, Richard
AU - Ekman, Mattias
AU - Faravelli, Carlo
AU - Fratiglioni, Laura
AU - Gannon, Brenda
AU - Jones, David Hilton
AU - Jennum, Poul
AU - Jordanova, Albena
AU - Jönsson, Linus
AU - Karampampa, Korinna
AU - Knapp, Martin
AU - Kobelt, Gisela
AU - Kurth, Tobias
AU - Lieb, Roselind
AU - Linde, Mattias
AU - Ljungcrantz, Christina
AU - Maercker, Andreas
AU - Melin, Beatrice
AU - Moscarelli, Massimo
AU - Musayev, Amir
AU - Norwood, Fiona
AU - Preisig, Martin
AU - Pugliatti, Maura
AU - Rehm, Juergen
AU - Salvador-Carulla, Luis
AU - Schlehofer, Brigitte
AU - Simon, Roland
AU - Steinhausen, Hans-Christoph
AU - Stovner, Lars Jacob
AU - Vallat, Jean-Michel
AU - den Bergh, Peter Van
AU - van Os, Jim
AU - Vos, Pieter
AU - Xu, Weili
AU - Wittchen, Hans-Ulrich
AU - Jönsson, Bengt
AU - Olesen, Jes
AU - CDBE2010Study Group
N1 - Copyright © 2011. Published by Elsevier B.V.
PY - 2011
Y1 - 2011
N2 - The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.
AB - The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.
U2 - http://dx.doi.org/10.1016/j.euroneuro.2011.08.008
DO - http://dx.doi.org/10.1016/j.euroneuro.2011.08.008
M3 - Journal article
VL - 21
SP - 718
EP - 779
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
IS - 10
ER -
ID: 40162733